HUMA Latest Press Releases

-- August 12, 2026 --

Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- August 10, 2026 --

Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA Business Wire 12:27 PM

-- August 7, 2026 --

Humacyte To Announce 2026 Second Quarter Financial Results and Provide Business Update on August 12, 2026 Globe Newswire 8:00 AM

-- July 27, 2026 --

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting Globe Newswire 8:00 AM

-- July 14, 2026 --

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access Globe Newswire 8:00 AM

-- June 15, 2026 --

Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting Globe Newswire 8:00 AM

-- June 10, 2026 --

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock Globe Newswire 9:08 PM

Humacyte, Inc. Announces Proposed Public Offering of Common Stock Globe Newswire 4:04 PM

Humacyte ATEV Met Superiority Primary Endpoint Compared to Standard of Care AV Fistula in Interim Analysis of V012 Phase 3 Study in Female Dialysis Access Patients Globe Newswire 4:01 PM

-- June 5, 2026 --

Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PRNewswire 3:52 PM

-- May 26, 2026 --

Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access Globe Newswire 8:00 AM

-- May 20, 2026 --

Humacyte Announces Symvess is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs Globe Newswire 8:00 AM

-- May 13, 2026 --

Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- May 12, 2026 --

Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer Globe Newswire 8:00 AM

-- May 8, 2026 --

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA Business Wire 6:01 PM

Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026 Globe Newswire 8:00 AM

-- April 27, 2026 --

Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026 Globe Newswire 8:00 AM

-- April 24, 2026 --

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA PRNewswire 10:03 PM

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess Globe Newswire 8:00 AM

-- April 22, 2026 --

Humacyte Appoints Jim Mercadante as Chief Commercial Officer Globe Newswire 8:00 AM

-- April 21, 2026 --

Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess for Vascular Trauma Repair Globe Newswire 8:00 AM

-- April 13, 2026 --

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA Business Wire 1:21 PM

-- April 9, 2026 --

Did Humacyte, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PRNewswire 3:50 PM

-- March 27, 2026 --

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- March 26, 2026 --

Humacyte Appoints Rick McElheny as Senior Vice President of Business Development Globe Newswire 8:00 AM

-- March 23, 2026 --

Humacyte To Announce 2025 Fourth Quarter and Year End Financial Results and Provide Business Update on March 27, 2026 Globe Newswire 8:00 AM

-- March 19, 2026 --

Humacyte Receives Symvess Purchase Commitment for Clinical Evaluation and Outreach Program in the Kingdom of Saudi Arabia Globe Newswire 8:31 AM

Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock Globe Newswire 8:30 AM

-- March 17, 2026 --

Humacyte Submits Marketing Authorization Application for Symvess in Israel for Vascular Trauma Repair Globe Newswire 8:00 AM